University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Salofalk granules
Status: Amber Sandocal effervescent tablets
Status: Amber Selegiline hydrochloride
Status: Amber Selegiline lyophisilate

For patients with swallowing difficulties only

Status: Amber Selenium capsules
Status: Amber Selenium tablets
Status: Amber Sevelamer tablets

Specialist recommendation.

Status: Amber Sirolimus solution

Post-transplant pre 2015

Status: Amber Sirolimus tablets

Post-transplant pre 2015

Status: Amber Sodium bicarbonate capsules

Specialist recommendations.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top